24 results on '"Ciardo, V."'
Search Results
2. P268 IBD and Covid-19 in italy: comparisons between first and second pandemic wave
- Author
-
Bezzio, C, primary, Costa, S, additional, Armuzzi, A, additional, Furfaro, F, additional, Ardizzone, S, additional, Milla, M, additional, Bossa, F, additional, Orlando, A, additional, Caprioli, F A, additional, Castiglione, F, additional, Viganò, C, additional, Ribaldone, D G, additional, Zingone, F, additional, Monterubbianesi, R, additional, Imperatore, N, additional, Festa, S, additional, Daperno, M, additional, Scucchi, L, additional, Ferronato, A, additional, Pastorelli, L, additional, Balestrieri, P, additional, Ricci, C, additional, Cappello, M, additional, Felice, C, additional, Coppini, F, additional, Alvisi, P, additional, Gerardi, V, additional, Variola, A, additional, Mazzuoli, S, additional, Lenti, M V, additional, Alessandro, S, additional, Buda, A, additional, Micheli, F, additional, Ciardo, V, additional, Casella, G, additional, Viscido, A, additional, Bodini, G, additional, Fiorino, G, additional, Vernero, M, additional, and Saibeni, S, additional
- Published
- 2022
- Full Text
- View/download PDF
3. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV 2 infection: an IG-IBD study
- Author
-
Bezzio, C., Armuzzi, A., Furfaro, F., Ardizzone, S., Milla, M., Carparelli, S., Orlando, A., Caprioli, F. A., Castiglione, F., Vigano, C., Ribaldone, D. G., Zingone, F., Monterubbianesi, R., Imperatore, N., Festa, S., Daperno, M., Scucchi, L., Ferronato, A., Pastorelli, L., Balestrieri, P., Ricci, C., Cappello, M., Felice, C., Fiorino, G., Saibeni, S., Coppini, F., Alvisi, P., Gerardi, V., Variola, A., Mazzuoli, S., Lenti, M. V., Pugliese, D., Allocca, M., Ferretti, F., Roselli, J., Bossa, F., Giuliano, A., Piazza, N., Manes, G., Sartini, A., Buda, A., Micheli, F., Ciardo, V., Casella, G., Viscido, A., Bodini, G., Casini, V., Soriano, A., Amato, A., Grossi, L., Onali, S., Rottoli, M., Spagnuolo, R., Baroni, S., Cortelezzi, C. C., Baldoni, M., Vernero, M., Scaldaferri, F., Maconi, G., Guarino, A. D., Palermo, A., D'Inca, R., Scribano, M. L., Biancone, L., Carrozza, L., Ascolani, M., Costa, F., Di Sabatino, A., Zammarchi, I., Gottin, M., Conforti, F. S., Bezzio, Cristina, Armuzzi, Alessandro, Furfaro, Federica, Ardizzone, Sandro, Milla, Monica, Carparelli, Sonia, Orlando, Ambrogio, Caprioli, Flavio Andrea, Castiglione, Fabiana, Viganò, Chiara, Ribaldone, Davide Giuseppe, Zingone, Fabiana, Monterubbianesi, Rita, Imperatore, Nicola, Festa, Stefano, Daperno, Marco, Scucchi, Ludovica, Ferronato, Antonio, Pastorelli, Luca, Balestrieri, Paola, Ricci, Chiara, Cappello, Maria, Felice, Carla, Fiorino, Gionata, Saibeni, Simone, and Francesca Coppini, Patrizia Alvisi, Viviana Gerardi, Angela Variola, Silvia Mazzuoli, Marco Vincenzo Lenti, Daniela Pugliese, Mariangela Allocca, Francesca Ferretti, Jenny Roselli, Fabrizio Bossa, Alessandra Giuliano, Nicole Piazza, Gianpiero Manes, Alessandro Sartini, Andrea Buda, Federica Micheli, Valeria Ciardo, Giovanni Casella, Angelo Viscido, Giorgia Bodini, Valentina Casini, Alessandra Soriano, Arnaldo Amato, Laurino Grossi, Sara Onali, Matteo Rottoli, Rocco Spagnuolo, Stefania Baroni, Claudio Cortelezzi, Monia Baldoni, Marta Vernero, Franco Scaldaferri, Giovanni Maconi, Alessia Dalila Guarino, Andrea Palermo, Renata D'Incà, Maria Lia Scribano, Livia Biancone, Lucio Carrozza, Marta Ascolani, Francesco Costa, Antonio Di Sabatino, Irene Zammarchi, Matteo Gottin, Francesco Simone Conforti
- Subjects
medicine.medical_specialty ,Settore MED/12 - GASTROENTEROLOGIA ,IBD ,Population ,Ulcerative ,Disease ,Lower risk ,Asymptomatic ,Inflammatory bowel disease ,Aged ,Humans ,SARS-CoV-2 ,Tumor Necrosis Factor Inhibitors ,COVID-19 ,Colitis, Ulcerative ,Crohn Disease ,Inflammatory Bowel Diseases ,IBD Treatments and Sars‐cov‐2 Infection ,Internal medicine ,medicine ,biologics ,Pharmacology (medical) ,education ,therapy ,education.field_of_study ,Hepatology ,business.industry ,INFLAMMATORY BOWEL DISEASE ,Gastroenterology ,medicine.disease ,Colitis ,Ulcerative colitis ,Pneumonia ,Original Article ,medicine.symptom ,business ,Cohort study - Abstract
Summary Background Older age and comorbidities are the main risk factors for adverse COVID‐19 outcomes in patients with inflammatory bowel disease (IBD). The impact of IBD medications is still under investigation. Aims To assess risk factors for adverse outcomes of COVID‐19 in IBD patients and use the identified risk factors to build risk indices. Methods Observational cohort study. Univariable and multivariable logistic regression was used to identify risk factors associated with pneumonia, hospitalisation, need for ventilatory support, and death. Results Of the 937 patients (446 with ulcerative colitis [UC]) evaluated, 128 (13.7%) had asymptomatic SARS‐CoV‐2 infection, 664 (70.8%) had a favourable course, and 135 (15.5%) had moderate or severe COVID‐19. In UC patients, obesity, active disease and comorbidities were significantly associated with adverse outcomes. In patients with Crohn's disease (CD), age, obesity, comorbidities and an additional immune‐mediated inflammatory disease were identified as risk factors. These risk factors were incorporated into two indices to identify patients with UC or CD with a higher risk of adverse COVID‐19 outcomes. In multivariable analyses, no single IBD medication was associated with poor COVID‐19 outcomes, but anti‐TNF agents were associated with a lower risk of pneumonia in UC, and lower risks of hospitalisation and severe COVID‐19 in CD. Conclusion The course of COVID‐19 in patients with IBD is similar to that in the general population. IBD patients with active disease and comorbidities are at greater risk of adverse COVID‐19 outcomes. IBD medications do not pose additional risks. The risk indices may help to identify patients who should be prioritised for COVID‐19 re‐vaccination or for therapies for SARS‐CoV‐2 infection., The course of COVID‐19 in patients with IBD patients is similar to that in the general population. IBD patients with active disease and comorbidities are at greater risk of adverse COVID‐19 outcomes. IBD medications do not pose additional risks.
- Published
- 2021
4. T06.02.21 SPLENIC RUPTURE FOLLOWING ROUTINE COLONOSCOPY
- Author
-
Ciardo, V., primary, Macor, C., additional, and Snidero, D., additional
- Published
- 2020
- Full Text
- View/download PDF
5. Prophylaxis of hepatitis B virus infection before liver transplantation, 1990–2001: a single-center experience
- Author
-
Marzano, A, Gaia, S, Ciardo, V, Premoli, A, Ghisetti, V, Salizzoni, M, and Rizzetto, M
- Published
- 2003
- Full Text
- View/download PDF
6. A monoclonal antibody to mammalian Angiotensin II AT1 receptor recognises one of the Angiotensin II receptor isoforms expressed by the eels
- Author
-
MARSIGLIANTE, Santo, MUSCELLA, Antonella, VILELLA, Sebastiano, NICOLARDI, Giuseppe, STORELLI, Carlo, INGROSSO L., CIARDO V., ZONNO V., VINSON G. P., HO M. M., Marsigliante, Santo, Muscella, Antonella, Vilella, Sebastiano, Nicolardi, Giuseppe, Ingrosso, L., Ciardo, V., Zonno, V., Vinson, G. P., Ho, M. M., and Storelli, Carlo
- Subjects
animal structures ,immunocytochemistry ,nonhuman ,eel ,intestine brush border ,angiotensin 2 [1 aspartyl 5 isoleucine] ,angiotensin 2 receptor - Abstract
Using labelled ligand-binding methods, previous studies have identified specific angiotensin II receptors (ANG II-Rs) in eel liver, kidney and intestine membranes. Isoelectric focusing on polyacrylamide gels also showed that there are two Ang II-R isoforms in eel liver, focusing at isoelectric points (pI) 6.5 and 6.7. These may have different functions. In contrast, eel enterocyte plasma membrane and renal brush border membranes contain only the pI 6.5 form. To characterize the eel receptors more fully, a newly developed monoclonal antibody (6313/G2) which selectively recognizes the AT(1) subtype of mammalian Ang II-R was used. In ligand-binding experiments, the preincubation of eel liver membranes with 6313/G2 antibody eliminated the specific [3,5-H-3]Tyr(4)-IIe(5)-Ang II binding. Moreover, Ang II-receptor complexes from solubilized liver membranes, which were immunoprecipitated by 6313/G2-coated beads, had a pI of 6.5. In immunoblotting experiments, the antibody recognized the isoform focusing at pI 6.5 in eel intestine and liver preparations, but not the liver pI 6.7 isoform. Immunoblotting of SDS gels showed that the antibody bound to a single protein of molecular mass of 75 kDa in eel liver, gill and kidney and to a doublet of molecular mass of about 74 and 75 kDa intestinal membrane preparations. Immunocytochemistry of paraffin-embedded and cryostat sections of eel liver, kidney, intestine and gill showed that antibody 6313/G2 bound to uniformly distributed intracellular sites and cell surface membrane in proximal tubular cells, absorptive intestinal cells, hepatocytes and chloride cells. It also stained endothelium and both the longitudinal and circular layers of smooth muscle cells in the intestine. The data suggest that the previously described Ang II-R from eel liver, kidney and intestine may be similar to the mammalian AT(1) subtype.
- Published
- 1996
7. Effect of tumour size on the association between pS2 and cathepsin D in primary breast cancer
- Author
-
Santo MARSIGLIANTE, Mottaghi, A., Muscella, A., Ciardo, V., Leo, G., Storelli, C., Marsigliante, Santo, Mottaghi, A, Muscella, Antonella, Ciardo, V, Leo, G, and Storelli, Carlo
- Subjects
skin and connective tissue diseases ,hormones, hormone substitutes, and hormone antagonists - Abstract
Previous studies have shown that pS2 and cathepsin D are linked in lymph node positive (N+) tumours, but not in tumours from lymph node negative (N-) patients. The purpose of this study was to understand whether or not size would effect the relationship between pS2 and cathepsin D. Findings were further extended to some subgroups of tumours obtained stratifying for T and N and particularly to the small (TI) but aggressive (N+) cancers (T1/N+) and to those of size greater than 2 cm (T2 and T3) but yet node negative (T2+T3/N-). Oestrogen (ER) and progesterone (PR) receptors, pS2 and cathepsin D concentrations were therefore assayed in 355 primary breast cancers. ER, PR, pS2 and cathepsin D did not correlate to nodal status and size of the tumours; no significant differences in the expression of these four biological factors between infiltrating ductal carcinomas without special features (NOS) and non-NOS carcinomas were found. Multivariate analysis performed among cathepsin D, ER, PR and pS2 indicated that, in T1 tumours, pS2 was the most important variable and the best predictor in cathepsin D determination, while such association was absent in T2 and T3 tumours. pS2 and cathepsin D significantly associated also in tumours obtained from N+ patients, and such correlation was highest in T1 tumours with positive axillary nodes (N+/T1). pS2 and cathepsin D did not associate in tumours taken from N- patients. Considering the NOS carcinomas, correlation between pS2 and cathepsin D in the N+, T1 and N+/T1 subgroups was higher in the poorly differentiated grade 3 with respect to grade 1 and grade 2 cancers. The data suggest that pS2 could have a role in cathepsin D expression and we hypothesise that such control could be an early biological event occurring in the development and progression of particularly aggressive (N+/grade 3), small (T1) breast cancers.
- Published
- 1995
8. Prophylaxis of hepatitis B virus infection before liver transplantation, 1990-2001: a single-center experience
- Author
-
Marzano, A., Gaia, S., Ciardo, V., Premoli, A., Ghisetti, V., Salizzoni, M., and Rizzetto, Mario
- Published
- 2003
9. PA.252 INTRAGASTRIC BALLOON FOR MORBID OBESITY: A RETROSPECTIVE EVALUATION OF EFFICACY AND TOLERANCE
- Author
-
Ciardo, V., primary, Zilli, M., additional, Berretti, D., additional, Macor, C., additional, Maieron, R., additional, Marino, M., additional, Pevere, S., additional, Rossitti, P., additional, and Zoratti, L., additional
- Published
- 2008
- Full Text
- View/download PDF
10. BATTERIEMIA DA CAMPYLOBACTER JEJUNI
- Author
-
Rondinelli, V., primary, Saraceno, R., additional, Focarelli, V., additional, Giglio, S., additional, Pascale, F., additional, Colosimo, M., additional, Riillo, G., additional, Mazzei, U., additional, Cristofaro, R., additional, Scerbo, P., additional, Cosco, L., additional, Ciardo, V., additional, and Masciari, R., additional
- Published
- 2005
- Full Text
- View/download PDF
11. 3 P Prophylaxis of HBV recurrence after liver transplantation in HBsAg-carriers. HBIG and lamivudine theraphy vs HBIG monotheraphy
- Author
-
Marzano, A., primary, Ciardo, V., additional, Gentilcore, E., additional, Gaia, S., additional, Ghisetti, V., additional, Lagget, M., additional, Smedile, A., additional, and Rizzetto, M., additional
- Published
- 2002
- Full Text
- View/download PDF
12. Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriers
- Author
-
Gaia, S., primary, Marzano, A., additional, Ciardo, V., additional, Gentilcore, E., additional, Lagget, M., additional, Smedile, A., additional, and Rizzetto, M., additional
- Published
- 2002
- Full Text
- View/download PDF
13. A monoclonal antibody to mammalian angiotensin II AT1 receptor recognizes one of the angiotensin II receptor isoforms expressed by the eel (Anguilla anguilla)
- Author
-
Marsigliante, S, primary, Muscella, A, additional, Vilella, S, additional, Nicolardi, G, additional, Ingrosso, L, additional, Ciardo, V, additional, Zonno, V, additional, Vinson, G P, additional, Ho, M M, additional, and Storelli, C, additional
- Published
- 1996
- Full Text
- View/download PDF
14. Multiple isoforms of the oestrogen receptor in endometrial cancer
- Author
-
Marsigliante, S, primary, Muscella, A, additional, Ciardo, V, additional, Puddefoot, J R, additional, Leo, G, additional, Vinson, G P, additional, and Storelli, C, additional
- Published
- 1995
- Full Text
- View/download PDF
15. EFFECT OF TUMOR SIZE ON THE ASSOCIATION BETWEEN PS2 AND CATHEPSIN-D IN PRIMARY BREAST-CANCER
- Author
-
MARSIGLIANTE, S, primary, MOTTAGHI, A, additional, MUSCELLA, A, additional, CIARDO, V, additional, LEO, G, additional, and STORELLI, C, additional
- Published
- 1995
- Full Text
- View/download PDF
16. A monoclonal antibody to mammalian angiotensin II AT1receptor recognizes one of the angiotensin II receptor isoforms expressed by the eel (Anguilla anguilla)
- Author
-
Marsigliante, S, Muscella, A, Vilella, S, Nicolardi, G, Ingrosso, L, Ciardo, V, Zonno, V, Vinson, G P, Ho, M M, and Storelli, C
- Abstract
Using labelled ligand-binding methods, previous studies have identified specific angiotensin II receptors (Ang II-Rs) in eel liver, kidney and intestine membranes. Isoelectric focusing on polyacrylamide gels also showed that there are two Ang II-R isoforms in eel liver, focusing at isoelectric points (pI) 6·5 and 6·7. These may have different functions. In contrast, eel enterocyte plasma membrane and renal brush border membranes contain only the pI 6·5 form.To characterize the eel receptors more fully, a newly developed monoclonal antibody (6313/G2) which selectively recognizes the AT1subtype of mammalian Ang II-R was used. In ligand-binding experiments, the preincubation of eel liver membranes with 6313/G2 antibody eliminated the specific [3,5-3H]Tyr4-Ile5-Ang II binding. Moreover, Ang II—receptor complexes from solubilized liver membranes, which were immunoprecipitated by 6313/G2-coated beads, had a pI of 6·5. In immunoblotting experiments, the antibody recognized the isoform focusing at pI 6·5 in eel intestine and liver preparations, but not the liver pI 6·7 isoform. Immunoblotting of SDS gels showed that the antibody bound to a single protein of molecular mass of 75 kDa in eel liver, gill and kidney and to a doublet of molecular mass of about 74 and 75 kDa in intestinal membrane preparations. Immunocytochemistry of paraffin-embedded and cryostat sections of eel liver, kidney, intestine and gill showed that antibody 6313/G2 bound to uniformly distributed intracellular sites and cell surface membranes in proximal tubular cells, absorptive intestinal cells, hepatocytes and chloride cells. It also stained endothelium and both the longitudinal and circular layers of smooth muscle cells in the intestine.The data suggest that the previously described Ang II-R from eel liver, kidney and intestine may be similar to the mammalian AT1subtype.
- Published
- 1996
- Full Text
- View/download PDF
17. Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer its correlation with sex steroid receptors, cathepsin D and histologic grades
- Author
-
Marsigliante, S., Muscella, A., Ciardo, V., and Barker, S.
- Published
- 1993
- Full Text
- View/download PDF
18. Multiple isoforms of the oestrogen receptor in endometrial cancer
- Author
-
Antonella Muscella, G. Leo, John R. Puddefoot, Santo Marsigliante, Carlo Storelli, Gavin P. Vinson, V Ciardo, Marsigliante, Santo, Muscella, Antonella, Ciardo, V, Puddefoot, Jr, Leo, G, Vinson, Gp, and Storelli, Carlo
- Subjects
Gene isoform ,medicine.drug_class ,Blotting, Western ,Breast Neoplasms ,Monoclonal antibody ,Epitope ,Immunoenzyme Techniques ,Endocrinology ,Mole ,Pi ,medicine ,Animals ,Humans ,Electrophoresis, Gel, Two-Dimensional ,Isoelectric Point ,Receptor ,Laryngeal Neoplasms ,Molecular Biology ,biology ,Isoelectric focusing ,Chemistry ,Carcinoma ,Uterus ,Antibodies, Monoclonal ,Molecular biology ,Endometrial Neoplasms ,Neoplasm Proteins ,Rats ,Receptors, Estrogen ,biology.protein ,Female ,Isoelectric Focusing ,Antibody - Abstract
We evaluated the presence and variability of oestrogen receptor (ER) isoforms in endometrial cancer by using [3H]oestradiol-labelled ERs and the H222 monoclonal antibody obtained from the Abbott enzyme immunoassay kit. Using isoelectric focusing (IEF), endometrial ER was shown to be composed of four different species, with pI values of 6·1, 6·3, 6·6 and 6·8, indistinguishable from the isoforms found in normal rat uterus, and human breast and larynx carcinomas. The isoforms at pI 6·3, 6·6 and 6·8, all sedimenting at 4S by sucrose gradient fractionation, showed, on two-dimensional SDS electrophoresis, relative masses of 50, 70 and 65 kDa respectively, equal to the masses previously found in breast cancer. These isoforms did not alter their pI values during IEF fractionation performed in a linear gradient of urea, while the pI 6·1, sedimenting at 8S, generated a new isoform at about 9 mol/l urea with pI 7·2 and a relative mass of 65 kDa. The urea-dissociated isoform (pI 7·2) was able approximately to double the antibody binding with respect to the non-dissociated oligomer, which suggested that some epitopes are 'masked', i.e. not accessible to the antibodies when ER is present in its complexed form. The evidence thus suggested that the oligomer at pI 6·1 contained a single 65 kDa ER form which, as a monomer, focused at pI 7·2. The variability in the ER isoform profile found in endometrial cancer was similar to the variability previously reported in breast and larynx carcinomas. The balance between these isoforms could be a dynamic parameter involved in the functionality of this receptor and consequently in cell transformation.
- Published
- 1995
19. Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic grades
- Author
-
Stewart Barker, Antonella Muscella, Santo Marsigliante, Carlo Storelli, Valerie Baker, Giuseppe Leo, Gavin P. Vinson, Ali Mottaghi, Vito Ciardo, Marsigliante, Santo, Muscella, Antonella, Ciardo, V, Barker, S, Leo, G, Baker, V, Mottaghi, A, Vinson, Gp, and Storelli, Carlo
- Subjects
Adult ,Cancer Research ,animal structures ,Receptor, ErbB-2 ,Blotting, Western ,Cathepsin D ,Breast Neoplasms ,Enzyme-Linked Immunosorbent Assay ,Gene product ,Immunoenzyme Techniques ,Breast cancer ,Proto-Oncogene Proteins ,medicine ,Humans ,Cathepsin ,Immunoradiometric assay ,biology ,medicine.diagnostic_test ,Carcinoma ,Sex hormone receptor ,Middle Aged ,medicine.disease ,Molecular biology ,ErbB Receptors ,Oncology ,Receptors, Estrogen ,Immunoassay ,biology.protein ,Immunoradiometric Assay ,Antibody ,Receptors, Progesterone - Abstract
One hundred and nine primary breast cancers were analysed to assess the presence of the HER-2/ neu gene product (p185), the oestrogen (ER) and the progesterone (PR) receptors, and the total cathepsin D status. An enzyme-linked immunosorbent assay (ELISA kit, Oncogene Science Inc.) was used for the evaluation of p185 in pellets obtained after a 100 000 × g centrifugation, ER and PR were measured by enzyme immunoassay (EIA kit, Abbott Laboratories), and the total cathepsin D content was evaluated by immunoradiometric assay (IRMA kit, CIS Biointernational). We showed that the ELISA kit is feasible to quantify the p185 present in breast cancer cell membranes, and that the detector antibody recognises a protein of approximately M r 185 000. The detected antigen was inversely related to both ER and PR, but it did not correlate to total cathepsin D. No significant differences were found in the expression of p185, ER, PR, cathepsin D between infiltrating ductal carcinomas without special features (NOS) and non-ductal (non-NOS) carcinomas. Nevertheless, in NOS carcinomas, a trend was observed in the p185 levels expressed by the tumours with different histological grades, in that p185 concentration was higher in the poorly differentiated grade 3 with respect to grade 2 and grade 1.
- Published
- 1993
20. Harmonization of ANA testing challenge: quantification strategy to accurately predict end-point titers avoiding serial dilution.
- Author
-
Carbone T, Pafundi V, Ciardo V, Infantino M, Muscella A, and D'Angelo S
- Subjects
- Fluorescent Antibody Technique, Indirect methods, Cytoplasm, Antibodies, Antinuclear
- Abstract
Despite the advantages of automated systems for antinuclear antibody (ANA) analysis, the prediction of end-point titers avoiding serial dilutions is still in progress. The aims of this study were to set a conversion table providing discriminant ranges of fluorescence signal intensity values (FI) corresponding to the end-point titers and validate this tool in a real-life laboratory setting. Eight hundred ninety-four serum samples were analyzed for ANA using Image Navigator System. In order to classify FI into non-overlapping groups corresponding to conventional end-point titers, statistical discriminant analysis was used. Validation study was performed calculating agreement and error rates between visual readings and conversion table of 1119 routine ANA positive samples. Setting of FI ranges corresponding to the end-point titers for different staining patterns was computed. For samples showing single pattern, the overall agreement between visual readings and conversion table was 98.4% for all titers ranging from 1:160 to 1:2560, of which 68.0% had the same titer and 30.4% were within ± one titer difference. Concordance rates according to ANA patterns were as follows: (1) nuclear 98.4%, of which 67.0% had the same titer and 31.4% ± one titer; (2) cytoplasmic 100%, of which 72.7% had the same titer and 27.3% than ± one titer; (3) mitotic 66.6%, of which 33.3% had more ± one titer. Our study developed a quantification method for autoantibodies titers assessment based on just one single sample dilution instead of traditional serial dilution approach, providing significant advantages in routine laboratory in terms of reduction in hand-on time and harmonization of results., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
21. The effects of adapted physical education sessions on the empathy of female students with overweight.
- Author
-
Slimi O, Marsigliante S, Ciardo V, Bahloul M, Selmi O, Jebabli N, and Muscella A
- Abstract
The global prevalence of childhood and adolescent overweight and obesity increases rapidly. Physical activity plays a major role in the prevention of obesity. The present study aimed to analyze the effect of adapted basketball sessions according to the empathic capacity of adolescent girls with overweight. Forty-two girls with overweight (age: 16.09 ± 0.85; years; height: 1.64 ± 0.67 m: weight: 73.02 ± 0.61 kg; BMI: 27.15 ± 1.37) volunteered to participate in the study and were randomly assigned to the experimental group (EG, n = 21) and control group (CG, n = 21). EG was submitted to a basketball intervention adapted to students with obesity while the CG performed classic basketball exercises for 7 weeks. Each week girls had 2 basketball teaching-learning sessions, lasting 50 min. The participants' empathy was assessed before and after the intervention using the Favre CEC. The results showed that adaptation intervention was associated with a significant emotional contagion decrease (Δ% = 0.466) and splitting with emotions (Δ% = 0.375), and with an empathy increase (Δ% = 1.387), in EG compared to CG. No significant difference was assessed in the empathy CG, before and after the intervention. This study demonstrated that adapted physical education classes could be an effective strategy to improve empathetic skills and inclusion of overweight girls as well as a means to prevent obesity., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Slimi, Marsigliante, Ciardo, Bahloul, Selmi, Jebabli and Muscella.)
- Published
- 2023
- Full Text
- View/download PDF
22. Efficacy of school-based intervention programs in reducing overweight: A randomized trial.
- Author
-
Marsigliante S, Ciardo V, Di Maglie A, My G, and Muscella A
- Abstract
Childhood obesity represents a serious public health problem and this study evaluates the effectiveness of a 6-month educational intervention on lifestyle, nutrient adequacy, and diet quality in the school setting in improving the knowledge and behavior of primary school children regarding correct eating habits. The strategy was implemented over a 6-month period and participants were randomly assigned to either the intervention group ( n = 200) or the non-intervention group (control group, n = 197). Participants had a mean body mass index of 18.3 ± 2.7 kg/m
2 and its variation in the intervention group (-2.7 ± 0.5 kg/m2 ) was significantly different from that in the control group (3.41 ± 0.8 kg/m2 ). In the experimental group, there were significant differences between the proportion of children who were overweight, underweight, normal weight, or obese before and after intervention ( p < 0.05). The best results were seen in the female sex, and after the intervention, there were no more girls with obesity. Furthermore, there were significant waist circumference decrement effects in the intervention group compared to the control group ( p < 0.05). Finally, many of the participating children acquired healthy eating habits. Therefore, the quantitative results obtained suggest that a school intervention program represents an effective strategy to prevent and improve the problem of childhood overweight and obesity., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Marsigliante, Ciardo, Di Maglie, My and Muscella.)- Published
- 2022
- Full Text
- View/download PDF
23. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
- Author
-
Saibeni S, Scucchi L, Dragoni G, Bezzio C, Miranda A, Ribaldone DG, Bertani A, Bossa F, Allocca M, Buda A, Mocci G, Soriano A, Mazzuoli S, Bertani L, Baccini F, Loddo E, Privitera AC, Sartini A, Viscido A, Grossi L, Casini V, Gerardi V, Ascolani M, Ruscio MD, Casella G, Savarino E, Stradella D, Pumpo R, Cortelezzi CC, Daperno M, Ciardo V, Nardone OM, Caprioli F, Vitale G, Cappello M, Comberlato M, Alvisi P, Festa S, Campigotto M, Bodini G, Balestrieri P, Viola A, Pugliese D, Armuzzi A, Fantini MC, and Fiorino G
- Subjects
- Critical Pathways, Disease Management, Humans, Inflammatory Bowel Diseases diagnosis, Inflammatory Bowel Diseases therapy, Italy epidemiology, Pandemics, Public Health Surveillance, Quality of Life, Surveys and Questionnaires, COVID-19 epidemiology, Inflammatory Bowel Diseases epidemiology, Standard of Care standards
- Abstract
Background and Aims: Restructuring activities have been necessary during the lockdown phase of the coronavirus disease 2019 (COVID-19) pandemic. Few data are available on the post-lockdown phase in terms of health-care procedures in inflammatory bowel disease (IBD) care, and no data are available specifically from IBD units. We aimed to investigate how IBD management was restructured during the lockdown phase, the impact of the restructuring on standards of care and how Italian IBD units have managed post-lockdown activities., Methods: A web-based online survey was conducted in two phases (April and June 2020) among the Italian Group for IBD affiliated units within the entire country. We investigated preventive measures, the possibility of continuing scheduled visits/procedures/therapies because of COVID-19 and how units resumed activities in the post-lockdown phase., Results: Forty-two referral centres participated from all over Italy. During the COVID-19 lockdown, 36% of first visits and 7% of follow-up visits were regularly done, while >70% of follow-up scheduled visits and 5% of first visits were done virtually. About 25% of scheduled endoscopies and bowel ultrasound scans were done. More than 80% of biological therapies were done as scheduled. Compared to the pre-lockdown situation, 95% of centres modified management of outpatient activity, 93% of endoscopies, 59% of gastrointestinal ultrasounds and 33% of biological therapies. Resumption of activities after the lockdown phase may take three to six months to normalize. Virtual clinics, implementation of IBD pathways and facilities seem to be the main factors to improve care in the future., Conclusion: Italian IBD unit restructuring allowed quality standards of care during the COVID-19 pandemic to be maintained. A return to normal appears to be feasible and achievable relatively quickly. Some approaches, such as virtual clinics and identified IBD pathways, represent a valid starting point to improve IBD care in the post-COVID-19 era.
- Published
- 2020
- Full Text
- View/download PDF
24. Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey.
- Author
-
Fantini MC, Biancone L, Dragoni G, Bezzio C, Miranda A, Ribaldone DG, Bertani A, Bossa F, Allocca M, Buda A, Mocci G, Soriano A, Guglielmi FW, Bertani L, Baccini F, Loddo E, Privitera AC, Sartini A, Viscido A, Grossi L, Casini V, Gerardi V, Ascolani M, Di Ruscio M, Casella G, Savarino E, Stradella D, Pumpo R, Cortelezzi CC, Daperno M, Ciardo V, Nardone OM, Caprioli F, Vitale G, Cappello M, Comberlato M, Alvisi P, Festa S, Campigotto M, Bodini G, Balestrieri P, Viola A, Pugliese D, Armuzzi A, Saibeni S, and Fiorino G
- Subjects
- Aftercare methods, Aftercare organization & administration, Betacoronavirus, COVID-19, Hospitalization statistics & numerical data, Humans, Italy epidemiology, Organizational Innovation, Remote Consultation methods, SARS-CoV-2, Surveys and Questionnaires, Coronavirus Infections diagnosis, Coronavirus Infections epidemiology, Coronavirus Infections prevention & control, Hospital Units organization & administration, Hospital Units statistics & numerical data, Hospital Units trends, Infection Control methods, Inflammatory Bowel Diseases diagnosis, Inflammatory Bowel Diseases epidemiology, Inflammatory Bowel Diseases therapy, Mass Screening methods, Pandemics prevention & control, Pneumonia, Viral diagnosis, Pneumonia, Viral epidemiology, Pneumonia, Viral prevention & control, Telemedicine methods, Telemedicine organization & administration
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.